Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-488410 in advanced non-small cell lung cancer
NCT01592617Phase 2Unknown
- Sponsor
- Shiga University
- Start
- May 2012
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
Phase 2, open-label trial of S-488410 in non-small cell lung cancer (NSCLC), sponsored by Shiga University. Primary endpoint: Overall Survival at 1 year. Status: unknown.
02
Drugs
S-488410
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01592617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01592617.